Clinical Trial Update: A Pilot Therapeutic Trial Using Hydroxyurea in Type I Spinal Muscular Atrophy Patients [Phase 1, Phase 2]

View source ↗

Summary

Pilot therapeutic trial evaluating hydroxyurea in patients with Type I spinal muscular atrophy (Phase 1/Phase 2) completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spinal Muscular Atrophy

Drugs mentioned

• HYDROXYUREA (Hydroxyurea)

Snippet

Sponsor: Stanford University | Conditions: Muscular Atrophy, Spinal | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2019-10-02